+34 985 20 74 34
effichronic@ficyt.es
EFFICHRONIC

Menu

Skip to content
  • Home
  • About
  • Partners
    • CSPA-SESPA-FICYT
    • CHUM
    • EMC
    • EOG
    • QISMET
    • UVEG-Polibienestar
  • Work Packages
  • Deliverables
  • Publications
  • News
  • Intranet
  • Newsletter

Newsletter

EFFICHRONIC > Newsletter

  • Newsletter 1, December 2017
  • Newsletter 2, June 2018
  • Newsletter  3, December 2018
  • Newsletter  4, June 2019
  • Newsletter  5, January 2020

Upcoming Events

There are no upcoming events.

View Calendar
Add
  • Add to Timely Calendar
  • Add to Google
  • Add to Outlook
  • Add to Apple Calendar
  • Add to other calendar
  • Export to XML

Follow us

EFFICHRONICFollow

This activity is part of the project EFFICHRONIC (GA 738127) which has received funding from the European Union’s Health Programme (2014- 2020)

EFFICHRONIC
effichronicEFFICHRONIC@effichronic·
24 Jan

Leprosy, also known as Hansen's disease (HD), has currently an effective treatment,but leprosy stigma continues to be problematic in developing countries where the disease is common. For this reason @WHO developes the strategy 2016−2020: Accelerating towards a leprosy-free world

Reply on Twitter 1220798425316249601Retweet on Twitter 1220798425316249601Like on Twitter 1220798425316249601Twitter 1220798425316249601
effichronicEFFICHRONIC@effichronic·
24 Jan

Leprosy, also known as Hansen's disease (HD), despite has currently an effective treatment, the stigma continues to be problematic in developing countries where the disease is common. For this reason @WHO developes the strategy 2016−2020 Accelerating towards a leprosy-free world

Reply on Twitter 1220617231232462849Retweet on Twitter 1220617231232462849Like on Twitter 1220617231232462849Twitter 1220617231232462849
effichronicEFFICHRONIC@effichronic·
17 Jan

January is time for New Year's resolutions. That are our healthy tips for 2020. #healthcare #2020resolutions #healthy #healthylifestyle

Reply on Twitter 1218068938510217217Retweet on Twitter 1218068938510217217Like on Twitter 1218068938510217217Twitter 1218068938510217217
effichronicEFFICHRONIC@effichronic·
16 Jan

Participation of the Observatory of Integrated Health Models (OMIS) in EFFICHRONIC
@NewhealthF @omisnh
http://effichronic.eu/participation-of-the-observatory-of-integrated-health-models-omis-in-effichronic/

Reply on Twitter 1217739262457794560Retweet on Twitter 12177392624577945603Like on Twitter 12177392624577945604Twitter 1217739262457794560
Retweet on TwitterEFFICHRONIC Retweeted
deliapm7Delia@deliapm7·
14 Jan

Avanzando en atención integrada en salud @PACASASTURIAS @effichronic @pisano_marta @sergiovalles77 @pifermu @Chefiasturias @cojamalovi @anamarsu @VivelyEs @Rociome82 @RosenArguelles https://twitter.com/PACASASTURIAS/status/1217025377006243840

PACAS@PACASASTURIAS

OBSERVATORIO DE MODELOS INTEGRADOS EN SALUD ( OMIS) https://activateportusalud.wordpress.com/2020/01/13/observatorio-de-modelos-integrados-en-salud-omis/

Reply on Twitter 1217058204498173953Retweet on Twitter 12170582044981739537Like on Twitter 121705820449817395313Twitter 1217058204498173953
Load More...

Project Information

This website is part of the project ‘EFFICHRONIC’ which has received funding from the European Union’s Health Programme (2014-2020). Ref: 738127.  Co-funded by the Health Programme of the European Union

Project Title

Enhancing health systems sustainability by providing cost-efficiency data based interventions for chronic management in stratified population based on clinical and socio-economic determinants of health.

More Info

  • Sitemap
  • Contact
  • Data Protection
  • Disclaimer

 

Copyright © EFFICHRONIC
Powered by WordPress , Theme i-excel by TemplatesNext.
MENU
  • Home
  • About
  • Partners
    • CSPA-SESPA-FICYT
    • CHUM
    • EMC
    • EOG
    • QISMET
    • UVEG-Polibienestar
  • Work Packages
  • Deliverables
  • Publications
  • News
  • Intranet
  • Newsletter
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok